LEADER 01585oam  2200469   450 
001 9910707376603321
005 20180316152348.0
035   $a(CKB)5470000002463750
035   $a(OCoLC)953525232
035   $a(EXLCZ)995470000002463750
100   $a20160713d2016      ua             0
101 0 $aeng
135   $aurbn||||m||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 10$aDXM Abuse Prevention Act of 2015 $ereport (to accompany H.R. 3250) (including cost estimate of the Congressional Budget Office)
210  1$a[Washington, D.C.] :$c[U.S. Government Publishing Office],$d[2016]
215   $a1 online resource (26 pages)
225 1 $aReport / 114th Congress, 2d session, House of Representatives ;$v114-672
300   $aTitle from title screen (viewed on July 13, 2016).
300   $a"July 8, 2016."
517   $aDXM Abuse Prevention Act of 2015 
606   $aDextromethorphan$xLaw and legislation$zUnited States
606   $aDrug abuse$xLaw and legislation$zUnited States
606   $aPharmacy$xLaw and legislation$zUnited States
608   $aLegislative materials.$2lcgft
615  0$aDextromethorphan$xLaw and legislation
615  0$aDrug abuse$xLaw and legislation
615  0$aPharmacy$xLaw and legislation
801  0$bGPO
801  1$bGPO
801  2$bGPO
801  2$bSTF
801  2$bOCLCO
801  2$bAZP
801  2$bOCLCQ
801  2$bGPO
906   $aBOOK
912   $a9910707376603321
996   $aDXM Abuse Prevention Act of 2015$93434663
997   $aUNINA